Inhalers for COPD provide steroids, bronchodilators, or combination drugs. The three types differ in the mechanism by which the medication is inhaled and have different instructions for use.

Background: In contrast to asthma, the indication for bronchodilators prior to bronchoscopy in patients with COPD has not been properly investigated. We therefore performed a randomized ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

“Patients with mild-to-moderate COPD who have low exercise tolerance are likely to experience poor respiratory health outcomes,” the investigators concluded. “Exercise tolerance may be considered one ...

belief that Ohtuvayre's bronchodilator and non-steroidal anti-inflammatory activity can re-define the COPD treatment paradigm." The encouraging sales figures come at a time when treatment options ...

This screening is also helpful in monitoring people who have already received a diagnosis of COPD, asthma, or both. Test results can help a doctor determine whether your current bronchodilator ...

The FDA approved inhaled ensifentrine (Ohtuvayre) as maintenance treatment for chronic obstructive pulmonary disease ... nebulized therapy acts as both a bronchodilator and non-steroidal anti ...

medical treatments and pulmonary rehabilitation. Medical treatments include bronchodilators, corticosteroids, antibiotics and mucolytic agents. Mucolytics are administered to reduce sputum ...

COPD is a leading cause of death worldwide ... effective way to slow the progression of the disease. Medications like bronchodilators and inhaled steroids can help open the airways, reduce ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...